Get Certified as a Psychedelic-Assisted Therapy Provider (PATP)*
Year-Long Program
January 2025 – October 2025
The fifth-wave of psychotherapy has arrived, and there’s no better time than now to get involved with psychedelic therapy. This program will get you trained to get involved with ketamine-assisted therapy right away, and get you prepared for the anticipated approvals of MDMA and Psilocybin in the near future.
Over 1,500 Students Trained
- 256 hours learning
- 90% live virtual learning
- Research-backed lectures and materials
- 30+ faculty members comprised of world-renowned leaders & top-tier experts
- Optional in-person ketamine Training Practicum
- Optional in-person psilocybin Training Practicum
- Supportive community of like-minded peers
Take your practice to a new frontier with the incredible power of psychedelic therapy.
Limited spaces available. Please apply now to ensure we can accommodate your application.
Our program is the highest-rated psychedelic therapy training program with an average rating of 4.7 out of 5 by over 1,500 students.
![](https://psychiatryinstitute.com/wp-content/uploads/2024/05/4.7-star-rating.png)
Collaborations
Colorado passed the Natural Medicine Health Act allowing for the therapeutic use of psilocybin as a mental health treatment with services expected by mid-2025. The Colorado Division of Regulatory Agencies (DORA) oversees the clinical regulation of this act. This groundbreaking act permits licensed medical providers and mental health professionals to provide psilocybin services for mental health treatments under state law. In order to be eligible to become a licensed facilitator in Colorado, the facilitator must graduate from a DORA approved program. IPI was the first approved program in Colorado. Participants who successfully complete and enroll in the Colorado Natural Medicine Track will become eligible to apply for licensure as a natural medicine facilitator in Colorado.
Oregon is the first state that passed a Psilocybin Services act with plans to deliver services as early as January, 2023. The Oregon Health Authority oversees the implementation of this progressive act. In order to be eligible to become a licensed facilitator in Oregon, the facilitator must graduate from an approved program. IPI has developed a specialized track within our Psychedelic-Assisted Therapy Training program for Oregon Psilocybin Services that has been approved by the Oregon Health Authority. Qualified Oregon residents who successfully complete the program and enroll in the optional Advanced Certificate in Psilocybin Therapy track will become eligible to apply for licensure as a psilocybin services facilitator.
IPI is proud to be collaborating with The American Society of Ketamine Physicians, Psychotherapists, and Practitioners. ASKP3 is a non-profit group of professionals dedicated to the safe clinical use of ketamine for mental health disorders and pain conditions. Members of the ASKP3 board act as partner participants in the IPI training and give regular feedback about the ketamine assisted psychotherapy curriculum.
IPI is proud to be collaborating with Usona Institute. Usona Institute is a 501(c)(3) non-profit medical research organization dedicated to supporting and conducting pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin and other consciousness-expanding medicines. Usona researchers act as partner participants in the IPI training and give regular feedback about the psilocybin assisted psychotherapy curriculum.
“The IPI community is so accepting and they really work hard to create a space for us to make connections with each other and also with the leaders.”
Mindy Tockman, MA, Missouri
IPI Psychedelic-Assisted Therapy Program Participant
Who should join the Psychedelic-Assisted Therapy Training?
This training is designed for therapists, physicians, nurses and other allied mental healthcare professionals who want comprehensive training in psychedelic-assisted therapy, in order to utilize ketamine as a psychedelic medicine and ready themselves for the anticipated approvals of MDMA and psilocybin.
This program is definitely for you if:
What Alumni Are Saying About the Program:
![](https://psychiatryinstitute.com/wp-content/uploads/2021/06/left-swirl-4.jpg)
The IPI Online Psychedelic-Assisted Therapy Program is a year-long course, taught by more than 30 experts in psychedelic-assisted therapy and research. This program will educate practitioners about the protocols of investigational psychedelic-assisted therapy treatments for PTSD, depression, anxiety, and more. It will also dive into the details of what research and practice have uncovered in the realm of psychedelic sciences, therapeutic processes unique to psychedelic therapy, preparation, dosing, integration, clinic models, and how psychedelics work in combination with other types of therapies.
This 256-hour program was designed from the ground up to be taken online, allowing a busy therapist to take it without traveling.
Participants who attend the in-person psilocybin Training Practicum live portion of the training will be eligible to become an IPI Certified Psychedelic Assisted Therapy Practitioner. If you do not choose the psilocybin in-person Training Practicum option you may still earn these documents upon the successful completion of program requirements, but you will not be eligible for the certification IPI offers.
Limited spots available
![](https://psychiatryinstitute.com/wp-content/uploads/2021/09/Randy-Buzan-e1632936146304.png)
“World-class scholars, profoundly inclusive seminar, lots of new material for me that has rekindled my interest in many areas of therapy in addition to psychedelics. Bravo!”
Randy Buzan, MD
Colorado
Who Can Apply:
You must have an advanced degree in either medicine or mental health in order to apply. If you are an early career mental health or medical professional, we encourage you to apply so we can discuss your situation and evaluate whether this program fits for your level of experience.
Professional Clinical Counselors (LPC)
The hard truth about mental illness
The field of therapy has achieved many important advances over the last few decades. But despite these advances we are unfortunately not making a significant dent in the massive mental health crisis on this planet.
2030
Depression is now the leading cause of disability worldwide and is predicted by 2030 to be the leading cause of the global burden of disease by the World Health Organization.
90%
90% of people experience trauma in their lifetime, according to a 2013 study. About 8 million people have PTSD in the U.S. in any given year. For our veterans, the PTSD and suicide rates are much higher. It’s hard to accept the statistic reported by the Veterans Administration that 22 veterans die by suicide each day.
1 in 5
adults experience some form of mental illness each year, and of these patients many have symptoms so severe their illness dramatically reduces their quality of life, limiting what they can and cannot do.
Tuition Details
Tuition w/o Training Practicums:
$10,000
Early Registration PIF Discount w/o Training Practicums Available Until September 30th, 2024:
$7,000
Add-On: In-Person Psilocybin Training Practicum (required for certification, does not include travel expenses, additional fees apply for Colorado track):
$3,000
Add-On: In-Person Ketamine Training Practicum Fees (does not include travel expenses):
$2,000
Limited spots available
Long-term payment plan options
may be available on your discovery call
may be available on your discovery call
![](https://psychiatryinstitute.com/wp-content/uploads/2021/09/Ektha-Aggarwal-LCSW-e1632937383677.png)
“I was so taken back at how inclusive this program was. As a therapist of color, many trainings and programs include culture as part of the program. This program was different; it did not include culture, it made it the foundation of learning from every aspect. I felt seen, heard, and understood.”
Ektha Aggarwal, LCSW
California
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/right-swirl.jpg)
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/doctor.jpg)
“Recent data suggest that ketamine, given intravenously, might be the most important breakthrough in antidepressant treatment in decades. First and most important, several studies demonstrate that ketamine reduces depression within six hours, with effects that are equal to or greater than the effects of six weeks of treatment with other antidepressant medications. Second, ketamine’s effects have been noted in people with treatment-resistant depression. This promises a new option for people with some of the most disabling and chronic forms of depression, whether classified as major depressive disorder or bipolar depression. Third, it appears that one of the earliest effects of the drug is a profound reduction in suicidal thoughts.” (October 1, 2014 NIMH Director’s Blog)
Tom Insel MD, former Provost of Harvard University, American neuroscientist and former Director of the National Institute of Mental Health (NIMH) from 2002 until November 2015
The Integrative Psychiatry Institute program is unlike any other psychedelic training offered. Not only will you learn from the world’s leading experts in psychedelic therapy, you also will learn an approach to mental healthcare that is long overdue.
Imagine not only offering clients a breakthrough with psychedelics, but also having an entirely new framework for mental health and the knowledge to properly set up clients for a path forward.
Watch the video to hear from an IPI Psychedelic Assisted Therapy Program participant about what it’s like to learn at the Integrative Psychiatry Institute and how we are different.
Join the revolution and apply
to become a psychedelic-assisted therapy provider.
to become a psychedelic-assisted therapy provider.
Limited spots available
How we are different from other psychedelic therapy trainings
-
-
Gain proficiency in a new therapy modality online in a year long format
-
Engage with over 30 faculty experts
-
Learn how to get involved in ketamine-assisted therapy now
-
Get prepared for MDMA therapy and Psilocybin therapy
-
90% live virtual learning with tons of faculty and teaching assistant contact
-
Community forum with faculty involvement for answers to your questions
-
In-person ketamine Training Practicum option
-
One of the very first approved training sites in Oregon offering a psilocybin-assisted therapy Training Practicum
-
Limited spots available
Featured Lecturers
You will be supported throughout your studies by a faculty of world-renowned leaders in psychedelic-assisted therapy and research. The faculty at the Integrative Psychiatry Institute is composed of the top-tier experts in their respective fields, teaching you the research, science and clinical skill sets needed for the use of ketamine, MDMA and psilocybin therapies.
![](https://psychiatryinstitute.com/wp-content/uploads/2021/04/Michael-Pollan-150x150-1.png)
Michael Pollan
For more than thirty years, Michael Pollan has been writing books and articles about the places where the human and natural worlds intersect: on our plates, in our farms and gardens, and in our minds. Pollan is the author of eight books, six of which have been New York Times bestsellers; three of them (including his latest, How to Change Your Mind) were immediate #1 New York Times bestsellers…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/04/Robin-Lester-Carhart-Harris-150x150-1.png)
Robin Lester Carhart-Harris
Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol, focused on the serotonin system, and an MA in Psychoanalysis from Brunel University, 2005. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Rick-Doblin-250x250-1.png)
Rick Doblin, PhD
Rick Doblin, PhD, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Gabor-Mate-150x150-1.png)
Gabor Maté, MD
Gabor Maté is a retired physician who, after 20 years of family practice and palliative care experience, worked for over a decade in Vancouver’s Downtown East Side with patients challenged by drug addiction and mental illness…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Annie-Mithoefer-1.png)
Annie Mithoefer, BSN
Annie Mithoefer, BSN, is a Registered Nurse living in Asheville, NC. She was co-investigator on two of the MAPS-sponsored Phase 2 clinical trials for individuals with PTSD and a pilot study treating couples combining MDMA-assisted psychotherapy with Cognitive Behavioral Conjoint Therapy for PTSD…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Michael-Mithoefer-250x250-1.png)
Michael Mithoefer, MD
Michael Mithoefer, MD, is a psychiatrist living in Asheville, NC, with a research office in Charleston, SC. In 2000 he began collaborating with MAPS on the first US Phase 2 clinical trial of MDMA-assisted Psychotherapy. He and his wife Annie have since conducted two of the six MAPS-sponsored Phase II clinical trials testing…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/10/photo_2022-10-26_03-56-46-edited.png)
Wilhelmina De Castro, LCSW
Wilhelmina De Castro, LCSW (She/They) is trained in KAP (Ketamine Assisted Psychotherapy) through PRATI (Psychedelic Research and Training Institute) and MDMA Assisted Psychotherapy through MAPS (Multidisciplinary Association of Psychedelic Studies…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Mary-Sanders-250x250-1.png)
Mary Sanders, LCSW
Mary is a Licensed Clinical Social Worker whose focus is on addressing trauma in communities of color and marginalized populations. She has worked with Black, Indigenous, (BIPOC), Veterans, immigrants and refugees from Iraq and Syria, foster youth, and LGBTQIA+ community members…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Anny-Ortiz-250x250-headshot-1.jpg)
Anny Ortiz, PhD
Anny Ortiz is a PhD candidate at the University of Wisconsin-Madison’s School of Human Ecology and the Clinical Therapeutic Lead at Usona Institute. Originally from Sonora, México, over the past 20 years she worked in a variety of therapeutic settings including outdoor behavioral health, long-term residential treatment…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Rosalind-Watts-250x250-1.png)
Rosalind Watts
Dr Rosalind Watts is a clinical psychologist and the founder of ACER Integration. She has been named as one of the 50 Most Influential People in Psychedelics as well as one of the top Top 16 Women Shaping the Future of Psychedelics.As the former clinical lead on the Psilocybin for Depression trial at Imperial College London, Dr Watts developed the ACE model of psychedelic assisted therapy ‘Accept, Connect, Embody’ and led…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/07/Joe-Tafur-250x250-1.png)
Joe Tafur
Joe Tafur, M.D., is a Colombian-American family physician originally from Phoenix, Arizona. After completing his family medicine training at UCLA, Dr. Tafur spent two years in academic research at the UCSD Department of Psychiatry in a lab focused on mind-body medicine. After his research fellowship, over a period of six years, he lived and worked in the Peruvian Amazon at the traditional healing center..
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Bossis-250x250-headshot.png)
Anthony P. Bossis
Anthony P. Bossis, Ph.D. is a clinical psychologist and clinical assistant professor of psychiatry at NYU Grossman School of Medicine and NYU Center for Psychedelic Medicine conducting FDA-approved clinical research with the psychedelic compound psilocybin since 2009. Dr. Bossis was director of palliative care research and co-principal investigator on the 2016 clinical trial demonstrating a significant reduction in emotional distress…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Bill-Richards-150x150-1.png)
William Richards, PhD
Bill A. Richards, PhD, a psychologist in the Center for Psychedelic and Consciousness Research in Baltimore, has been implementing research studies with psilocybin within the psychiatry department of the Johns Hopkins School of Medicine since 1999. He also is associated with the Program in Psychedelic Therapies and…
Read more
![https://psychiatryinstitute.com/wp-content/uploads/2019/03/joan-borsyenko.png](https://psychiatryinstitute.com/wp-content/uploads/2019/03/joan-borsyenko.png)
Joan Borysenko, PhD
Joan Borysenko, Ph.D., is a distinguished pioneer in integrative medicine and is a world-renowned expert in the mind/body connection. Her work has been foundational in an international healthcare revolution that recognizes the role of meaning and spirituality in health and healing…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/10/Rohini-Kanniganti.png)
Rohini Kanniganti, MD
Rohini Kanniganti, MD, MSPH, HMDC is a Boulder based Board Certified Family Physician. She has served in hospice and palliative care for over a decade, currently at the Mountain Valley Hospice and Palliative Care in NC. She completed a fellowship in Integrative Psychiatry through the Integrative Psychiatry Institute, and serves at the Integrative Psychiatry Centers..
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/swirlleft2.jpg)
Lecturers
The faculty at the Integrative Psychiatry Institute is composed of the top-tier experts in their respective fields, teaching you the latest breakthroughs in psychiatric care.
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Melissa-Lavasani-250x250-1.png)
Melissa Lavasani, MPP
Melissa Lavasani is Founder and Chief Executive Officer of Washington, DC-based Psychedelic Medicine Coalition, a national association committed to advancing the science supporting psychedelic medicine…
Read more
![https://psychiatryinstitute.com/wp-content/uploads/2019/03/Arielle-Schwartz-e1552664156734.png](https://psychiatryinstitute.com/wp-content/uploads/2019/03/Arielle-Schwartz-e1552664156734.png)
Arielle Schwartz, PhD
Arielle Schwartz, PhD is a licensed clinical psychologist, EMDR Therapy consultant, and certified yoga instructor with a private practice in Boulder, Colorado…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/01/Megan-Oxley-250x250-1.png)
Megan Oxley, MD
Megan Oxley, MD is the founder and medical director of Michigan Progressive Health. A Board Certified Emergency Medicine physician, Dr. Oxley graduated from prestigious Wayne State University in 2009…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Mary-Sanders-250x250-1.png)
Mary Sanders, LCSW
Mary is a Licensed Clinical Social Worker whose focus is on addressing trauma in communities of color and marginalized populations. She has worked with Black, Indigenous, (BIPOC), Veterans, immigrants and refugees from Iraq and Syria, foster youth, and LGBTQIA+ community members…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Berra-Yazar-Klosinski-250x250-1.png)
Berra Yazar-Klosinski, PhD
Berra Yazar-Klosinski, PhD, is a Deputy Director of the 501(c)(3) non-profit Multidisciplinary Association for Psychedelic Studies (MAPS). She also serves as the Chief Scientific Officer (CSO) for the MAPS Public Benefit Corporation (MAPS PBC)…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Andrew-Bryant-250x250-1.png)
Andrew Bryant, MPH, LICSW
Andrew Bryant, MPH, LICSW is a clinical social worker, psychotherapist, and co-Director of North Seattle Therapy & Counseling, with a clinical focus on the impact of climate change and ecological crisis on mental health. He also provides Ketamine-Assisted Therapy (KAT), in collaboration with Telos Transformational Therapies….
Read more
![https://psychiatryinstitute.com/wp-content/uploads/2019/03/Chuck-Raison-Photo-Original-file-400x600.png](https://psychiatryinstitute.com/wp-content/uploads/2019/03/Chuck-Raison-Photo-Original-file-400x600.png)
Charles Raison, MD
Charles Raison, MD, is the Mary Sue and Mike Shannon Chair for Healthy Minds, Department of Psychiatry, University of Madison, WI. He is the co-author of “The New Mind-Body Science of Depression” published by W.W. Norton in 2017…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Joseph-McCowan-250x250-1.png)
Joseph McCowan, PsyD
Joseph McCowan, PsyD, is a licensed clinical psychologist and psychotherapist, currently working in Los Angeles as a co-therapist in the MAPS sponsored phase 3 clinical trials of MDMA-Assisted Psychotherapy for PTSD…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Devon-Christie-250x250-1.png)
Devon Christie, MD
Dr. Devon Christie is a family doctor with a focused practice in chronic pain and mental health. She is certified in Functional Medicine, Mindfulness Based Stress Reduction, Relational Somatic Therapy for trauma resolution…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/04/Brooke-Balliett-150x150-1.png)
Brooke Balliett, LMFT
Brooke Balliett, LMFT, is a licensed marriage and family therapist in Los Angeles, CA. Brooke has a passion for treating psychological, spiritual, emotional and relationship challenges through the development of self-awareness, emotional intelligence and recognition of the healing power we each inherently hold inside of us…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/06/Torsten-Passie-250x250-1.png)
Torsten Passie MD, MA
Torsten Passie MD, MA is a professor of psychiatry and psychotherapy at Hannover Medical School and visiting scientist at the Goethe University Franfurt/Main (Germany). He studied philosophy, sociology (M.A.) at Leibniz-University Hannover and medicine at Hannover Medical School…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Katrina-Michelle-250x250-1.png)
Katrina Michelle, PhD, LCSW
Katrina Michelle, PhD, LCSW earned her Ph.D. in Psychology from The Institute of Transpersonal Psychology at Sofia University and her Master’s in Social Work from Stony Brook University. For her doctoral research she conducted a heuristic study on Exploring Resistance to Spiritual Emergence….
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Ian-Wickramasekera-250x250-1.png)
Ian Wickramasekera, PsyD
Ian Wickramasekera, PsyD, a clinical psychologist and have been a teacher of transpersonal psychology for over 20 years. He taught counseling related courses at Naropa University since 2015 and previously taught at Saybrook University…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Margaret-Brako.png)
Margaret Brako, LCSW
Margaret provides psychotherapy and Ketamine Assisted Therapy at Sage Integrative Health (Berkeley, CA). Earlier this year, she was part of the team that offered the clinic’s first Ketamine Assisted Therapy training…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Shannon-Clare-Carlin-150x150-1.png)
Shannon Carlin, MA, LMFT
Shannon Carlin, MA, LMFT, is the Director and Head of Training and Supervision at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS)…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Veronika-Gold-250x250-1.png)
Veronika Gold, MA, LMFT
Veronika Gold is a co-founder of Polaris Insight Center, and a psychotherapist licensed in California and Oregon. Veronika is a lead trainer at Polaris Insight Center Ketamine and Psychedelic Assisted Therapy training program..
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/06/Sara-Lewis-250x250-1.png)
Sara Lewis, PhD, LCSW
Sara Lewis, PhD, LCSW, is an Associate Professor and Chair of Contemplative Psychotherapy and Buddhist Psychology at Naropa University, where she also serves as Faculty Director for Psychedelic Studies…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Albert-Garcia-Romeu-250x250-1.png)
Albert Garcia-Romeu, PhD
Albert Garcia-Romeu (Roh-May-Oh), Ph.D. is an Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/03/nicholas-spiers.png)
Nicholas Spiers
Nicholas Spiers is an anthropologist and documentary filmmaker. He co-founded Agua de Rayo, a non-profit civil organization based in Mexico’s Sierra Mazateca, which is invested in visual ethnography and community projects and which also has an interest in Mazatec psychoactive plant use….
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/03/Kylea-Taylor-250x250-1.png)
Kylea Taylor, MS, LMFT
Kylea Taylor, M.S., LMFT is a licensed psychotherapist (CA MFC #34901) who has been thinking, writing, and teaching about ethics for almost three decades. She developed InnerEthics®, a self-reflective, selfcompassionate, approach to relational ethics which she is now teaching in psychedelic psychotherapy trainings…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/David-Yaden-250x250-1.png)
David B. Yaden, PhD
David B. Yaden, PhD, completed his doctorate at the University of Pennsylvania and is now an Assistant Professor at Johns Hopkins University School of Medicine. His research focus is on the psychology, neuroscience, and psychopharmacology of spiritual, self-transcendent, and other positively transformative experiences…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Kelley-ODonnell-250x250-1.png)
Kelley O’Donnell, MD, PhD
Dr. Kelley O’Donnell is a board-certified psychiatrist and an Assistant Professor of Psychiatry at the NYU Grossman School of Medicine, and the Director of Therapist Training at the NYU Langone Center for Psychedelic Medicine. After receiving her medical degree and a PhD in Neuroscience at UCLA…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Andrea-Rosati-250x250-1.png)
Andrea Rosati, MD, PhD
Dr. Andrea Rosati is an Assistant Professor of Psychiatry at the University of California, San Francisco. Since 2018, she has been a Study Therapist and Study Physician in the Phase 2 and 3 MAPS PBC-sponsored clinical trials of MDMA-AT for PTSD at UCSF. She is also an Associate Supervisor and Assistant Educator in the MAPS PBC’s Educational Programs….
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Tim-Spalla-250x250-1.png)
Tim Spalla, MA, LPCC
Tim Spalla is a Licensed Professional Counselor-Candidate and owner of Agile Wellness Group, a private therapy practice in Denver, Colorado. Before entering the mental health field, he spent nearly 20 years living and working overseas, first as a US Army Ranger Intelligence Specialist with multiple combat deployments in Iraq….
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Joanna-Simundic-250x250-1.png)
Joanna Simundic, RCSW, RCC
Joanna Simundic is the sole founder, owner and psychotherapist at Embracing Change Therapy, a private psychotherapy practice she started in 2013. She supports individuals in processing traumatic material using a variety of techniques such as: Eye Movement Desensitization Reprocessing, Mindfulness….
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Chantelle-Thomas-250x250-1.png)
Chantelle Thomas, PhD
Dr. Chantelle Thomas is a clinical psychologist and Executive Clinical Director of Windrose Recovery-a multi-level residential addiction treatment program offering detoxification, intensive outpatient programming and integrated ketamine assisted psychotherapy. Dr. Thomas is also involved in clinical research trials..
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Ido-Siemion-250x250-1.png)
Ido Siemion, PhD
Ido Siemion, PhD., is a MAPS PBC (Multidisciplinary Association for Psychedelic Studies) trainer, a Hakomi trainer and co-founder of the Hakomi Institute of Israel. He holds a PhD in East West Psychology and a M.A. in Somatic Psychology, both from the California Institute of Integral Studies….
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Marc-Aixala-250x250-1.png)
Marc B. Aixalà, MS
Marc B. Aixalà is a Telecommunication Engineer and Psychologist with Master studies in Integrative and Strategic Therapy. He has been trained in the therapeutic use of Non Ordinary States of Consciousness. Also trained in MDMA assisted-psychotherapy for PTSD by MAPS PBC and the use of psilocybin for treatment-resistant depression..
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Mendel-Kaelen-250x250-1.png)
Mendel Kaelen, PhD
Mendel Kaelen is the founder and CEO of Wavepaths, a startup providing music both for and as psychedelic therapy. Prior to this, he worked as a PhD and postdoctoral neuroscientist at Imperial College London since 2012, where his research was the first to demonstrate music’s central role in psychedelic therapies…..
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/right-swirl.jpg)
![](https://psychiatryinstitute.com/wp-content/uploads/2021/09/Karmen-Thulin-PsyD-e1632943674769.png)
“As a trauma psychologist it really was so good at giving all of the important pieces of entering PAT from a scientific, inclusive, and intrapersonal stance. I love how it included the best and most relevant psychological theory all from theorists, researchers, and people leading the work.”
Karmen Thulin, PsyD
Texas
Home Group Facilitators
![](https://psychiatryinstitute.com/wp-content/uploads/2022/06/Liz-Willis-250x250-1.png)
Elizabeth Willis RN, MS
Elizabeth Willis RN, MS, PMHNP(c) is a co-founder of the Organization for Psychedelic and Entheogenic Nurses (OPENurses) and has practiced as an emergency department registered nurse (ED RN) in critical care settings for a decade. Passionate about disaster response and humanitarian work, her nursing path has taken her as far as Bolivia, Ecuador, Cambodia, Laos, and Zimbabwe…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/06/Emily-McKay-250x250-1.png)
Emily McKay, MA, LPC
Emily is a Licensed Professional Counselor and a Ketamine Assisted Therapist at Integrative Psychiatry Centers in Boulder. She received her master’s degree in Contemplative Psychotherapy and Buddhist Psychology from Naropa University and is certified in Hakomi Mindful Somatic Therapy, and Psychedelic Assisted Therapy…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/03/Kosu-Boudreau-250x250-1.png)
Kosu Boudreau
Kosu Boudreau is a graduate from IPI’s Psychedelic-Assisted Therapy Cohort #1 and currently works as a ketamine assisted therapist in Toronto, Canada. She also completed the MAPS MDMA therapy training…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/03/Carsten-Fisher-250x250-1.png)
Carsten Fisher
Carsten Fisher is a behavioral psychologist by training, experienced in working with populations diagnosed with an array of mental health challenges, and is a passionate harm reductionist and educator. Carsten has been a student of psychedelic-assisted healing modalities and integration practice…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/12/Jordan-Dobrowski-250x250-1.png)
Jordan Dobrowski, LCSW
Jordan Dobrowski is a Licensed Clinical Social Worker and Certified Psychedelic-Assisted Therapy Provider with experience providing psychotherapy to youth and adults in both English and Spanish. She received her Master’s in Social Work with certificates in Trauma-Informed Care and Culturally Responsive Mental Healthcare for Immigrant Families from the University of Chicago in 2018…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/06/left-swirl-4.jpg)
Teaching Assistants
![](https://psychiatryinstitute.com/wp-content/uploads/2022/06/Amanda-Ream-250x250-1.png)
Amanda Ream, LCSW, MSW, MEd
Amanda (she/her/hers) holds a dual-masters degree in Clinical Social Work and Human Sexuality Education from Widener University. Originally from Philadelphia, Amanda now resides in Denver, Colorado and runs a private psychotherapy practice here…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/06/Jess-Breeman-250x250-1.png)
Jessica Breemen, MSW, SWC
Jessica Breemen, MSW, SWC has focused her energy on social entrepreneurship, micro-to-macro health & wellness, criminal justice and drug policy reform, full spectrum harm/risk reduction, benefit maximization, and integrative medicine-assisted care…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/07/Michael-Donisi-250x250-1.png)
Michael Donisi
Michael Donisi is currently pursuing an M.A. in Clinical Mental Health Counseling at Regis University and has a profound interest in the re emerging field of Psychedelic-Assisted Psychotherapy. With over two years of experience in this domain, Michael also has delved deep into integrative medicine, LGBTQIA+ issues, clinical operations…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/01/Zane-Guilfoyle-250x250-1.png)
Zane Guilfoyle, LPC, LAC
Raised in the Colorado mountains, Zane wears shorts and Chacos even in the midst of the winter. He enjoys skiing powder, “wander” hiking, “creative” camping and is always up for an adventure. With a master’s in counseling from Naropa University, Zane has a passion for LGBTQ communities and sexual health…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/06/Tori-Buckley-250x250-1.png)
Tori Buckley, MA, LPC
Tori (she/her) received a master’s degree in Transpersonal Counseling Psychology from Naropa University, and is a Licensed Professional Counselor in both Louisiana and Colorado. She is a graduate of the first cohort of IPI’s Psychedelic-Assisted Therapy Training program…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Melissa-Landis-Padron-250x250-headshot.png)
Melisssa Landis-Padron
Melissa Landis-Padron has a Masters’s Degree in Education and has been a K-12 teacher for over 20 years. Specializing in behavioral supports, mindfulness, and Sensory Integration program development. She has also been a community events coordinator for the City of Eugene creating connections and networking with community partners to host community music…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/03/Kris-Isaacs-250x250-1.png)
Kris Isaacs
Kris Isaacs is a registered licensed therapist and certified addictions specialist in the state of Colorado. He received Master of Arts in Transpersonal Counseling Psychology from Naropa University in Boulder Colorado and is a graduate of IPI’s Psychedelic Assisted Therapy training, Cohort 2…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/03/Jessica-Cook-250x250-1.png)
Jessica Cook
Jessica Cook, MA, LMFT is a passionate couples and family therapist in Denver. With over 12 years of experience, she continuously strives to support her clients in reaching their potential as they enhance their relationships and connections to the world around them…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/03/Thad-Frye-250x250-1.png)
Thad Frye
Thad Frye is a Licensed Clinical Social Worker in private practice in Boulder, CO. He specializes in a somatic modality called Brainspotting. Thad is a certified Brainspotting Consultant who supervises therapists wanting to become certified in the modality. In his private practice he specializes in grief, sports performance and psychedelic integration…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Amy-Koehlinger-250x250-1.png)
Amy Koehlinger
Amy Koehlinger is an educator with over 25 years of experience in post-secondary and graduate settings. She holds a Ph.D. in Religious Studies from Yale University, and an M.A. in U.S. History from the University of Oregon. Amy researches, writes, and teaches about historical intersections of religious experience and structures of power in the United States…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Arah-Gould-250x250-1.png)
Arah Gould, MA, LPC
Arah is a mental health therapist, with close to 20 years of experience, working with adults in private practice and drawing from mindfulness, psychodynamic, and somatic approaches. In addition to her private practice, she also has nearly a decade of experience supporting adoptive and foster parents with trauma-informed parenting strategies and resources on child…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Molly-Powers-250x250-1.png)
Molly Powers, MA, LMT
Molly is an explorer of mind, body, and soul. In 2009 she received her Master’s degree from The California Institute of Integral Studies from the department of Philosophy, Cosmology, and Consciousness. For two incredible years she traversed the realms of the mind and soul and is still integrating all of the profound teachings and experiences…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Douglas-Wingate-250x250-headshot.png)
Douglas Wingate, DTCM, FMHC, L.Ac
Douglas Wingate, DTCM, FMHC, L.Ac, is a Doctor of Chinese Medicine, licensed acupuncturist, herbalist, and certified clinician in hyperbaric oxygen therapeutics specializing in neurological, emotional, and neuro-cognitive conditions as well as acute and chronic pain having worked in private practice and OHSU hospital’s neurology department…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Jessica-Corp-250x250-1.png)
Jessica L. Corp, LPC
Jessica L. Corp is a relational therapist who, for the last 12 years, has been collaborating with people who experience both symptoms of mental health disorders and symptoms of drug and alcohol use disorders. She has provided individual and group therapy in Residential Treatment Centers and Outpatient treatment…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Lynne-Shinto-250x250-headshot.png)
Lynne Shinto, ND, MPH
Lynne Shinto, ND, MPH (She, Her) is a Naturopathic Physician who is deeply involved in moving forward the integration of all types of medicine. She received her naturopathic medicine degree at Bastyr University in Kenmore, WA, and her Master of Public Health at Oregon Health & Science University in Portland, OR. She is a certified psychedelic-assisted therapy provider…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Melinda-Halpern-250x250-headshot.png)
Melinda Halpern
Melinda earned her Masters in Counseling from Oregon State University and a Masters in Public Administration from Lewis and Clark College. Her early work as a therapist centered on young children and adolescents, emphasizing Autism Spectrum Disorders and trauma. She has added expanded her work with adults and is a Level 2 EMDR therapist…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Michele-Soleimani-250x250-headshot.png)
Michele Soleimani, LCSW
Michele Soleimani is a licensed clinical social worker who has been in private practice for 15 years, with a focus on treating complex PTSD. Prior to that she worked in community based mental health, HIV/AIDS education, intensive outpatient and partial hospitalization programs for close to 10 years. Originally from New York City…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Noora-Via-250x250-1.png)
Noora Via LMT, CHP
Noora is a Certified Hakomi Practitioner (a mindfulness center somatic psychotherapy) and has been a Massage Therapist for 18 years specializing in Myofascial Release and Craniosacral Therapy. She has completed extensive training through the Hakomi Institute, Maui School of Therapeutic Massage…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/03/Hannah-Dresdner-250x250-1.png)
Shosh Dresdner
Shosh Dresdner, LCSW (she/her) is a bilingual (English & Spanish) Denver based, telehealth therapist. Her practice incorporates a holistic approach hinging on modalities aimed at supporting processes of mind, body, and spirit. She is trained in EMDR, Somatic Therapies, Psychedelic Assisted Psychotherapy…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/03/Sonya-Som-250x250-1.png)
Sonya Som
Sonya Som, MA, LMFT, LPCC, provides psychotherapy, hypnotherapy, the therapeutic integration of psychedelics, EMDR, and Brainspotting to individuals and couples. She feels passionately about the healing effects of psychedelics and the greater collective’s need for deep healing and growth…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/right-swirl.jpg)
“I’ve known people, throughout this program, who had very little knowledge [about psychedelics] and by the end of this program they’re implementing new strategies in their practice to help people.”
Lynn Knight, MA, LCMHC, RPT, Tennessee
IPI Psychedelic-Assisted Therapy Program Participant
Leadership Team
The psychedelic therapy training is led by top-tier experts in their respective fields, teaching you the latest breakthroughs in psychedelic-assisted therapy.
![Headshot of founder Will Van Derveer, MD](https://psychiatryinstitute.com/wp-content/uploads/2019/01/Will-founder.png)
Will Van Derveer, MD
Co-Founder
Medical Director
Will Van Derveer, MD, Co-Founder of the Integrative Psychiatry Institute and Integrative Psychiatry Centers, conducted MDMA clinical research and provided MDMA-assisted psychotherapy with MAPS for several years. He has been providing and teaching others how to provide ketamine-assisted therapy for several years. In the 2021 publication of the “Handbook of Medical Hallucinogens”…
Read more
![Headshot of founder Keith Kurlander, MA, LPC](https://psychiatryinstitute.com/wp-content/uploads/2019/01/Keither-founder.png)
Keith Kurlander, MA, LPC
Co-Founder
Clinical Director
Keith Kurlander, MA, LPC is the Co-founder of the Integrative Psychiatry Institute and the Integrative Psychiatry Centers. He has practiced integrative psychotherapy for over a decade. After years of treating highly complex patients, as well as a personal journey of overcoming complex mood-related issues, he turned toward integrative psychiatric practices as a key component to understanding the healing process…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/Jamie-Davila-150x150-1.png)
Jaime Davila, MA, LPC
Director of Psychedelic Trainings
Jaime received his Master of Arts in Counseling from Regis University and is a Licensed Professional Counselor in the state of Colorado. Originally Born in Puerto Rico, and raised in a military family, Jaime has spent time in Europe, Central America, and many states in the US. He brings a unique blend of interpersonal, analytic and technical skills to his healing work and also provides services in Spanish…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/10/Rohini-Kanniganti.png)
Rohini Kanniganti, MD
Physician Team Lead
Rohini serves at The Denver Hospice and Optio Palliative Health Services. Board Certified in Family Medicine, Dr. Kanniganti has been practicing in Colorado for over a decade. Dr. Kanniganti graduated from Penn State University with a Bachelor of Science in Chemistry and received a Master of Science in Public Health and medical degree from the University of North Carolina…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/03/SaraGaelGiron.png)
Sara Gael, MA, LPC
Lead Facilitator
Sara is a psychedelic therapist and educator with expertise in MDMA-Assisted Therapy, ketamine-assisted therapy, psychedelic risk reduction, and psychedelic professional development. She served as the Course Director for the IPI Psychedelic-Assisted Therapy Training from 2020-2022 and currently serves as Lead Facilitator for the training…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/10/photo_2022-10-26_03-56-46-edited.png)
Wilhelmina De Castro, LCSW
Head of Diversity, Equity, and Inclusion and Home Group Team Leader
Wilhelmina De Castro, LCSW (She/They) is trained in KAP (Ketamine Assisted Psychotherapy) through PRATI (Psychedelic Research and Training Institute) and MDMA Assisted Psychotherapy through MAPS (Multidisciplinary Association of Psychedelic Studies. In addition to supporting IPI with building DEI initiatives, Wilhelmina works as PRATI’s KAP Training Scholarship Program Coordinator…Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/10/photo_2022-10-26_03-56-47-edited.png)
Jaime Dias Delgado, LCSW
Diversity, Equity & Inclusion Consultant
Jaime Dias Delgado, LCSW (he, they) is a Culture & Identity consultant and trauma therapist with a practice rooted in liberation psychology. Jaime received an MSW from Fordham University and subsequently worked in professional-level foster care, intimate partner violence, youth gender and sexuality education, elementary education curriculum…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Mailae-Halstead.png)
Mailae Halstead, M.S, NCC
Diversity, Equity & Inclusion Consultant
Mailae Halstead is a Nationally Certified Counselor currently based out of Tolland, Connecticut. While much of her work is spent treating PTSD and OCD using empirically supported treatments, she is passionate about practicing psychedelic-assisted psychotherapy that centers cultural humility and empowerment…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2021/07/Drew-Snyder-250x250-1.png)
Drew Snyder, MS, LPC
Head of Psilocybin Training Practicum
Drew is a professional counselor in private practice in Oregon, specializing in psychedelic-assisted psychotherapy. He received comprehensive training in this field through IPI in conjunction with MAPS, as well as Bodhi Academy. Drew’s enthusiasm lies in exploring the efficacy of non-ordinary states of consciousness to facilitate healing from trauma, addiction, depression, and mental distress…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/12/Jay-Thooft-250x250-1.png)
Jay Thooft
Director of Admissions
Jay serves as the Director of Admissions with IPI overseeing the enrollment for the Psychedelic Assisted Therapy Training Program. Jay works with individual students as well as large group practices, hospital systems, and behavioral health clinics to get their clinicians up to speed on Psychedelic Assisted Therapy…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2023/12/imageedit_2_2328072354.png)
Victoria Gutiérrez Arribère
Head of Student Experience
Victoria brings a wealth of experience collaborating with healthcare professionals. Her involvement in the field of public health has provided her with valuable insights into mental healthcare and community well-being, strengthening her dedication to roles focused on making a meaningful impact on people’s lives…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2022/02/Blakely-Saucier-250x250-1.png)
Blakely Saucier
Head of Faculty & Retreats
Blakely Saucier received her BFA in Theatre Design and Technical Production from the University of Memphis, and spent the first ten years of her career working as a Stage Manager, Lighting Designer, Program Manager, and Artistic Director for both professional and youth theatre companies. Equipped with a passion for plant medicine, community engagement…
Read more
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/product.jpg)
Earn Continuing Education Credits (CE)
![](https://psychiatryinstitute.com/wp-content/uploads/2023/04/Jointly-Accredited-Provider-ok-e1681937748832.png)
We were approved for 19.75 CE credits for the prior cohort and we are anticipating approval for this cohort as well.
In support of improving patient care, this activity has been planned and implemented by CME Outfitters, LLC and Integrative Psychiatry Institute, LLC. CME Outfitters, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
![](https://psychiatryinstitute.com/wp-content/uploads/2023/07/APA-logo.png)
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
FYI … No Partial Credit.
For programs that involve a variety of sessions (e.g., conferences, conventions), credit should be awarded on a session-by-session basis. Each individual session for which credit is awarded must meet the Standards and Criteria; e.g., each session much have its own stated learning objectives, each session must be evaluated separately. Providers must have a system for determining which sessions were attended (e.g., sign-in sheet, credit log).
What You’ll Get
The IPI Psychedelic-Assisted Therapy Training has been designed to take advantage of recent advances in online education, with 256 hours of learning, allowing participants to get involved with psychedelic therapy and to sharpen your skills and get certified if you are already practicing.
Every session is recorded in your online library, and readily available, in case your schedule does not permit you to attend a certain session online. In addition, you will have access to your online library for an entire year after the program ends
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/online-pre.png)
Online Prerequisite Modules
This series, available to you before the start of the actual program, is designed to introduce the basics so you can get started learning today.
![](https://psychiatryinstitute.com/wp-content/uploads/2019/03/iconfinder_6_4261001.png)
Virtual Intensive I
Our training begins with the Live Virtual Intensive consisting of highly-engaging talks by expert faculty where you will learn the fundamentals of psychedelic-assisted therapy while building community.
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/onlinemodules.png)
Online Lectures
10 months of weekly 60 minute online lectures and panel discussions to help you become an expert in psychedelic-assisted therapy.
![](https://psychiatryinstitute.com/wp-content/uploads/2019/03/iconfinder_6_4261001.png)
Large Group Seminars
10 Months of bi-weekly 120 minute online groups in breakout rooms where you will practice and discuss different techniques of psychedelic-assisted therapy.
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/zoomclinical.png)
Home Group Sessions
Two zoom calls per month in your small group assignments discussing cases, homework and other relevant topics.
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/zoomclinical.png)
Community Forum
Community discussion and interaction with teaching assistants and faculty will occur through an innovative private online portal throughout the program, to ensure you have the support to maximize your learning experience
![](https://psychiatryinstitute.com/wp-content/uploads/2019/03/iconfinder_6_4261001.png)
Virtual Intensive II
Our training wraps up with Live Virtual Intensive, with advanced topics and innovative specialized methods to ensure participants are confident in their new knowledge, and have the expertise to apply it correctly in their practices.
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/online-pre.png)
In-person Ketamine Training Practicum (Optional)
Our training wraps up with Live Virtual Intensive, with advanced topics and innovative specialized methods to ensure participants are confident in their new knowledge, and have the expertise to apply it correctly in their practices.
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/online-pre.png)
In-person Psilocybin Training Practicum (Optional)
Attend a 4-day, hands-on psilocybin experience in Eugene, Oregon, designed to deepen your understanding of classical psychedelics and explore emergent group dosing formats. Within a 12-person group, you’ll alternate between the roles of guide and participant, offering an enriching opportunity for learning and self-discovery. Physical attendance is necessary to meet the “Certified Psychedelic Assisted Therapy Provider” certification exam criteria; however, undertaking a psilocybin therapy session at this training is optional. Please note, additional practicum requirements apply in order to complete the Colorado Natural Medicine Track and Oregon Psilocybin Services Track.
![](https://psychiatryinstitute.com/wp-content/uploads/2021/09/Amy-Schimmel-MSW-LCSW-e1632944918749.png)
“This training has been well organized, professional and so very inspiring! It brings together all of the elements that are at times siloed in medicine, mental health and spirituality. Highly recommend!”
Amy Schimmel, LCSW
Arizona
Curriculum Details
In order to create a program that leads to a certification, the program focuses on five modules to gain expertise as a psychedelic-therapy provider.
Research and Science
- Explore the current psychotherapy research protocols
- Grasp the chemistry and pharmacology
- Learn about proposed mechanisms of action
- Get up to date on MDMA, Psilocybin, and Ketamine research
- Find out about the history of psychedelic research
- Understanding dosing protocols
- Medical safety issues to know about
- Regulatory Compliance topics
Therapeutic Process
- Use techniques specific to psychedelic therapy
- How to work with the Inner Healing Intelligence
- Applying attachment theory in therapeutic process
- Implementing somatic therapy techniques, parts work, & IFS
- How to be with non-ordinary states of consciousness
- Understanding Trauma Neuroscience
- Providing adequate preparation and integration
- Essentials of the Set and Setting
- Navigating the safe uses of therapeutic touch
Integrative Treatment Planning
- How to achieve values-based behavior change
- Addressing an expanded spectrum of root causes
- What to know about medications and supplements
- How to maintain progress with lifestyle changes
- Mind-body practices to support integration
- Basic nutritional recommendations for optimal mental health
Professional Development
- Psychedelics inside an integrative model of mental health
- Essentials of harm reduction
- Ethics in psychedelic assisted therapy
- Providing culturally competent care
- Diversity, Equity, Inclusion in psychedelic medicine
- Addressing access to care issues
- Professional Liability
- Policy, Advocacy, and Collaboration
- Learn about clinic models and individual psychotherapy
practice settings
Intrapersonal Development
- Therapist Self-Regulation
- Transference and Countertransference
- Protecting boundaries in psychedelic sessions
- Practicing therapist self-care
- Exploring breathwork
- Embracing ongoing personal growth work
- Understanding the importance of mystical & spiritual
experiences - Using meditation & mindfulness for self exploration
- Developing therapist self-growth practices
Limited spots available
Diversity, Equity, and Inclusion
At IPI we take the position that different perspectives and backgrounds are necessary for a vibrant community to thrive. In the field of psychedelic-assisted therapy, there are not enough providers who identify as members of groups who have been oppressed or marginalized. Particularly poignant is the reality that therapists who do not identify as members of the BIPOC and LGBTQIA+ communities struggle with providing care that is both culturally competent and sensitive to the unique challenges of oppression and marginalization. We are committed to a diverse faculty, equity among the learners and education that creates cultural competency.
Scholarships
BIPOC & LGBTQIA+ Scholarships
At IPI, we understand that different perspectives and backgrounds are necessary for a vibrant community to thrive. In the field of psychedelic-assisted therapy, there are not enough providers who identify as members of groups who have been oppressed or marginalized. Particularly poignant is the reality that therapists who do not identify as members of the BIPOC and LGBTQIA+ communities can struggle with providing care that is both culturally competent and sensitive to the unique challenges of oppression and marginalization. In support of our commitment to inclusivity and diversity, we will award 25 scholarships at a 50% discount to qualified applicants who demonstrate financial need. Please sign up for a call and you will receive instructions afterward on how to apply. Scholarships are awarded on a first-come, first-served basis.
Veteran Discounts
We are committed to supporting military veterans to gain access to training in psychedelic-assisted therapy. If this is you, please ask about our 35% discount for veterans on your discovery call.
Need-Based Scholarships
We understand that psychedelic therapy training is a considerable investment and not everyone has the resources in order to undertake a comprehensive program as such. In support of our commitment to inclusivity and diversity, we will award 25 needs-based scholarships at a 50% discount to qualified applicants. Please sign up for a call and you will receive instructions afterward on how to apply. Scholarships are awarded on a first-come, first-served basis.
In-person Psilocybin Training Practicum in Eugene, Oregon
Tuesday, Wednesday, Thursday, Friday
Dates: TBD
![](https://psychiatryinstitute.com/wp-content/uploads/2023/05/iStock-9943246321.jpg)
We are excited to offer this incredible, hands-on psilocybin facilitation training experience, designed to deepen your understanding of classical psychedelics and explore emergent group dosing formats. In group administration format, you’ll have the opportunity to observe and facilitate psilocybin services. Attending as a student practicing is necessary to meet the “Certified Psychedelic Assisted Therapy Provider” certification criteria; however, undertaking a psilocybin therapy session is completely optional and is facilitated by our founders’ other companies, Evolve Therapeutics and Conscious Encounters. Please note, Oregon psilocybin services are not medical or mental health treatments, therefore different qualification processes apply. Most people do qualify for psilocybin services based on Oregon rules as psilocybin generally speaking is very safe.
In-person Ketamine-Assisted Therapy Training Practicum in Boulder, Colorado
Friday, Saturday, Sunday
Dates: TBD
A unique feature of this program is the opportunity to gather in person with a group of fellow learners for a 3-day (Friday, Saturday, Sunday) Training Practicum in Boulder, CO. Experiential learning is considered by many psychedelic therapy pioneers to be essential to gaining proficiency in psychedelic therapy. Gathering with colleagues to learn about psychedelic therapy is also a great opportunity to build community.
During this Training Practicum, you will practice and will also be given the option to participate as a client. Participating as a client is not required to attend the Training Practicum. This practicum is optional and not required for certification.
Colorado Natural Medicine Track
Students who wish to apply for licensure in Colorado as a natural medicine facilitator with psilocybin must sign up for our six-day practicum option in Oregon. The tuition for the six-day practicum is $4,000 in addition to general program costs. It’s possible we will have a practicum site in Colorado during this cohort in which case the Colorado track practicum will be moved there.
Additionally, Colorado requires 50 hours of post-graduation supervision. We have plans to create a program in order to accommodate this, however, fees have not yet been established.
Oregon Psilocybin Services Track
All students are enrolled in this track when they sign up for the four-day psilocybin practicum. Students who wish to apply for licensure in Oregon as a psilocybin facilitator must also attend three additional observation days in order to meet the entire practicum requirement required in Oregon. Please ask for more details.
How Can I Use This Psychedelic Training?
A Message From the Co-founder:
The IPI certification is designed for qualified professionals who already have a significant foundation of relevant training and experience providing mental healthcare. Certification and certificates of completion will be awarded upon successful completion of the program and demonstrating core competencies.
The only psychedelic medicine currently available nationwide to provide in a medical is ketamine. Additionally, Colorado and Oregon have passed acts to allow psilocybin services. In this program you will learn about how to get involved, ethically and safely, with ketamine-assisted therapy. Psilocybin-assisted therapy is currently in phase 3 FDA trials, and [for now] remain on US DEA schedule 1, making it illegal to use outside an approved research setting on a federal level. MDMA-assisted is currently being reviewed by FDA with a decision in August, 2024. As a training institute, we support following the outcomes of validated research, and, upholding the laws in the territory in which you reside.
Tuition Details
Tuition w/o Training Practicums:
$10,000
Early Registration PIF Discount w/o Training Practicums Available Until September 30th, 2024:
$7,000
Add-On: In-Person Psilocybin Training Practicum (required for certification, does not include travel expenses, additional fees apply for Colorado track):
$3,000
Add-On: In-Person Ketamine Training Practicum Fees (does not include travel expenses):
$2,000
Limited spots available
Long-term payment plan options
may be available on your discovery call
may be available on your discovery call
![](https://psychiatryinstitute.com/wp-content/uploads/2019/02/moneyback.jpg)
Our Guarantee
Our commitment to furthering your education
The knowledge, experience, and confidence you will gain from attending the IPI Psychedelic Assisted Therapy Training is unparalleled.
No other program provides a learning experience like this, from the quality of training to the world-class faculty ready for your every question.
The IPI Psychedelic Therapy Training is a year-long online course that will not only help you feel confident providing ketamine, but will also bring your knowledge base up to date on the latest evidence.
Make an investment in yourself and your education. Take your practice to a new level of patient care.
And if you’re not happy with the program, you can get a full refund within the first 30 days after the date that you pay and register. Simply reach out to our team, let us know what we could have done better, and your refund will be on its way.
Have more questions? [email protected]
Frequently Asked Questions
When are the online lectures?
Our online lectures will be scheduled in a regular time-slot during business hours so you can plan your schedule accordingly. However, if you cannot attend any of these lectures you will always have access to recordings of them in your online library.
What type of mentorship will I receive?
There will be time during the large group seminars for feedback from teaching assistants, as well as during the live experience if you attend. In addition there is time for Q+A during every live lecture, as well as a community forum. You will also be assigned to a small group mentorship video call that meets for an hour twice a month with rotating faculty, where you can review case studies and ask further questions. The mentorship calls will also be added to your online library.
How long can I access my course materials?
Your course materials will be available for a full year following the completion of the program.
Will I be automatically certified at the completion of the program?
Currently, no national board certification exists for psychedelic-assisted therapy. If you choose to partake in the optional live Training Practicum, you will become eligible for certification and will be awarded it upon successful completion of the program and demonstrating core competencies. If you choose not to participate, you will still receive a certificate of completion upon successful completion of the program and demonstrating core competencies.
Do I have to attend the two live intensives?
You are expected to attend both online conferences. We will be doing important group exercises, in addition to other community building activities. Please contact us with any extenuating circumstances.
When will I get access to the prerequisite materials?
Immediately! As soon as you register, you will have received an account on the IPI website. The prerequisite material will be uploaded over the course of March.
What format are the recordings in?
Recordings are video, audio and transcripts. Generally, a slide deck is also used by the presenter.
What are IPI’s equity practices?/ How do I know IPI is safe for *my marginalized identity experience*?
– Scholarships and affinity weekends/opportunities
– Current gender program audit with plans for ongoing audits of curriculum
– Infusion of JEDI competencies throughout versus one or two DEI-specific lectures the whole year